Europe’s Divisional Patent Trap: How Big Pharma Delays Generics Without Ever Losing in Court
Europe’s “Divisional Patent Trap”: How Big Pharma Can Delay Generics Without Losing in Court
If you’ve ever wondered how a company can keep generics off the shelf for years—despite losing key legal battles—this is the mechanism.
Europe’s patent system …
